Khanna Gaurav, Damle Nishikant Avinash, Agarwal Shipra, Roy Maitrayee, Jain Deepali, Mallick Soumyaranjan, Ahmed Shamim, Tripathi Madhavi, Gogia Ajay
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Indian J Nucl Med. 2017 Jan-Mar;32(1):46-49. doi: 10.4103/0972-3919.198478.
Mixed phenotypic acute leukemia (MPAL) is a rare clinical entity. MPAL associated with myeloidsarcoma (MS) is still rarer with only three cases mentioned in English literature. MS has been described in myriads of location, most commonly in skin, gums and lymph nodes. Although theoritically possible, it is very rare to find MS involving the thyroid gland. The diagnosis of MS can be elusive, very often masquerades and mislabeled as lymphoma. A high index of clinical suspicion coupled with PET/CT findings along with morphological clues and thorough peripheral blood, and bone marrow evaluation is mandatory for arriving at the definitive diagnosis. We report the case of a 58-year-old female presenting with thyroid swelling that was subsequently diagnosed to be MS of the thyroid with underlying MPAL (mixed myeloid/B-cell) only after F-FDG PET/CT, which revealed an unusual abnormal pattern of multifocal intense FDG uptake in the thyroid gland.
混合表型急性白血病(MPAL)是一种罕见的临床实体。与髓系肉瘤(MS)相关的MPAL更为罕见,英文文献中仅提及3例。MS已在众多部位被描述,最常见于皮肤、牙龈和淋巴结。虽然理论上有可能,但累及甲状腺的MS非常罕见。MS的诊断可能难以捉摸,常常伪装并被误诊为淋巴瘤。要做出明确诊断,必须高度临床怀疑,结合PET/CT结果以及形态学线索,并对全外周血和骨髓进行全面评估。我们报告一例58岁女性,因甲状腺肿大就诊,经F-FDG PET/CT检查后,最终诊断为甲状腺MS并伴有潜在的MPAL(混合髓系/B细胞型),该检查显示甲状腺出现多灶性强烈FDG摄取的异常模式。